Factor analysis of dynamic series (FADS) in somatostatin receptor imaging

Journal of Nuclear Medicine

Volumn 40, Issue 1, 1999, Pages 33-39

  Kolesnikov Gauthier, Hélène ^a   Huglo, Damien ^a,b   Nocaudie, Marie ^a   Marchandise, Xavier ^a  

^a UNIV LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

111In pentetreotide; Factor analysis of dynamic series; Factor analysis of dynamic structure; Neuroendocrine tumors; Somatostatin receptor imaging

Indexed keywords

PENTETREOTIDE IN 111; SOMATOSTATIN RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; COMPUTER PROGRAM; FEMALE; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; MALE; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; RECEPTOR BINDING; SCHOOL CHILD; THYROID CARCINOMA; TUMOR SCINTISCANNING;

EID: 0032923504     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. 3)-octreotide: The Rotterdam experience with more than 1000 patients. Eur J Nucl Med. 1993;20:716-731.
2. Jamar F, Fiasse R, Leners N, Pauwels S. Somatostatin receptor imaging with Indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patient management. J Nucl Med. 1995;36:542-549.
3. Dorr U, Franck-Raue K, Raue F, et al. The potential value of somatostatin receptor scintigraphy in medullary thyroid carcinoma. Nucl Med Commun. 1993;14:439-445.
4. Hannequin P, Liehn JC, Valeyre J. Analysis of image sequences in nuclear medicine. #2. Application of factor and analysis methods [in French]. J Med Nucl Biophys. 1989;13:125-137.
5. Barber DC. The use of principal components in the quantitative analysis of gamma camera dynamic studies. Phys Med Biol. 1980;25:283-292.
6. Houston AS, MucLeod MA, Sampsom FD. Principal components analysis as an aid to classification of renal dynamic studies. Eur J Nucl Med. 1979;4:295-299.
7. Frouin K, Bazin JP, Di Paola R. FAMIS: A software package for functional feature extraction from biomedical multidimensional images. Comput Med Imaging Graph. 1992;16:81-89.
8. Nijran KS, Barber DC. Factor analysis of dynamic function studies using a priori physiological information. Phys Med Biol. 1986;31:1107-1117.
9. Samal M, Surova H, Karny M, Marikova F, Michalova K, Dienstbier Z. Enhancement of physiological factors in factor analysis of dynamic studies. Eur J Nucl Med. 1986;12:280-283.
10. Bénali H, Buvat I, Frouin F, Bazin JP, Di Paola R. A statistical model for the determination of the optimal metric in factor analysis of medical sequences (FAMIS). Phys Med Biol. 1993;38:1065-1080.
11. Cavailloles F, Bazin JP, Di Paola R. Factor analysis in gated cardiac studies. J Nucl Med. 1984;25:1067-1079.
12. Lamas-Olier A, Giammarile F, Frouin F, et al. Factor analysis for the study of the initial biodistribution of labeled octreotide [Abstract in French]. Med Nucl. 1994;18:238.
13. Krausz Y, Shibley N, De Jong RBJ, Yaffe S, Glaser B. Gallbladder vizualization with In-111-labeled octreotide. Clin Nucl Med 1994;19:133-135.
14. Bell GI, Yasuda K, Kong H, et al. Molecular biology of somatostatin receptor. In: Somatostatin and Its Receptors (Ciba Foundation Symposium 190). Chichester, United Kingdom: John Wiley and Sons: 1995:65-88.
15. 1)-octreotide for detection of somatostatin receptor-positive tumors in rats. Life Sci. 1991;49:1593-1601.
16. Kolesnikov-Gauthier H, Huglo D, Nocaudie M, Marchandise X. Factor analysis of dynamic structures applied to somatostatin receptor imaging in the diagnosis of medullary thyroid carcinoma [in French]. Med Nucl. 1997;21:219-225.
17. 1-octreotide in man assessed by whole body scintigraphy. Acta Radiol. 1994;35:53-57.
18. Bong SB, Vanderlaan JG, Louwes H, Schuurman JJ. Clinical experience with somatostatin receptor imaging in lymphoma. Semin Oncol. 1994;21(suppl 13):46-50.
19. 123-Tyr-3-octreolide. J Nucl Med 1992;33:652-658.